School of Public Health, Medical College of Soochow University, 199 Ren Ai Road, Suzhou, 215123, China.
The 3rd People's Hospital of Xiangcheng District, Suzhou, 215134, China.
Sci Rep. 2021 Feb 25;11(1):4652. doi: 10.1038/s41598-021-84367-7.
It remains unclear whether leukocyte-related parameters could be used as biomarkers to differentiate metabolically unhealthy overweight/obesity (MUO) from metabolically healthy overweight/obesity (MHO). We aimed to examine the differences in the distribution of leukocyte-related parameters between older adults with MHO and MUO and the correlations of leukocyte-related parameters with individual components of metabolic abnormality. In the Weitang Geriatric Diseases Study on older Chinese adults aged 60 years or above, 404 individuals with MHO and 480 with MUO contributed to the analysis. Overweight/obesity was defined as body mass index (BMI) of 25 kg/m or more. MHO and MUO were discriminated based on the Adult Treatment Panel III (ATP III) criteria. Leukocyte-related parameters were assessed using an automated hematology analyzer. All leukocyte-related parameters except monocytes were elevated in MUO group compared with MHO group (all P < 0.05). The prevalence of MUO increased by 24% with each 10/L increase of leukocytes after adjusting for confounders in the multiple-adjusted model (P < 0.01) and each unit elevation of other parameters except lymphocytes and monocytes were significantly associated with the presence of MUO (all P < 0.01). Trend tests revealed a linear trend for the association between MUO and all the leukocyte-related parameters (all P for trend < 0.05). Significant interactions between leukocyte-related parameters and sex on the presence of MUO were observed (all P value for interaction < 0.05). Higher leukocyte-related parameters were found in patients with MUO than those with MHO and were associated with higher prevalence of MUO which seems to be sex-dependent. Further studies are needed to see whether these parameters could be used as biomarkers for the screening or diagnosis for MUO in clinical or public health practice.
白细胞相关参数是否可作为生物标志物来区分代谢不健康的超重/肥胖(MUO)与代谢健康的超重/肥胖(MHO)仍不清楚。我们旨在研究 MHO 和 MUO 老年人白细胞相关参数的分布差异,以及白细胞相关参数与代谢异常个体成分的相关性。在对中国 60 岁及以上老年人的卫塘老年疾病研究中,共有 404 名 MHO 患者和 480 名 MUO 患者参与了分析。超重/肥胖定义为体重指数(BMI)≥25kg/m²。MHO 和 MUO 是根据成人治疗小组 III(ATP III)标准区分的。白细胞相关参数使用自动血液分析仪进行评估。除单核细胞外,所有白细胞相关参数在 MUO 组中均高于 MHO 组(均 P<0.05)。在多因素调整模型中,在校正混杂因素后,白细胞每增加 10/L,MUO 的患病率增加 24%(P<0.01),除淋巴细胞和单核细胞外,其他参数的每个单位升高均与 MUO 的存在显著相关(均 P<0.01)。趋势检验显示 MUO 与所有白细胞相关参数之间存在线性趋势(所有趋势 P 值均<0.05)。白细胞相关参数与性别对 MUO 存在的交互作用均有显著差异(所有交互 P 值均<0.05)。MUO 患者的白细胞相关参数高于 MHO 患者,且与 MUO 的高患病率相关,这种相关性似乎是性别依赖性的。需要进一步的研究来确定这些参数是否可以作为 MUO 筛查或诊断的生物标志物,用于临床或公共卫生实践。